Adrian Hargrave, CEO of SEEEN, explains how the Company is now funded through to profitability.  Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Factsheet and Blog

29 Apr 2024 07:00

RNS Number : 3124M
Intl. Biotechnology Trust PLC
29 April 2024
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Latest Factsheet and Blog

 

 

IBT's factsheet for the month ended 31 March 2024 is now available directly via its website. Please click here, then 'latest factsheet'.

 

The global healthcare industry benefits from several fundamental tailwinds that look capable of driving structural growth for many years, if not decades, into the future. The increasingly complex demands of a global population that is growing older, richer and sicker, are driving steadily rising demand for pharmaceutical products and the industry is responding with accelerating innovation.

 

This topic is explored in the latest blog post, Older, richer, sicker - the implications of global demographic megatrends on the biotech opportunity, from IBT's investment managers Ailsa Craig and Marek Poszepczynski, which can be read here: https://www.schroders.com/en-gb/uk/individual/content/older-richer-sicker-the-implications-of-global-demographic-megatrends-on-the-biotech-opportunity/

 

To sign up for IBT updates by email, please click here.

 

 

ENDS

 

 

Enquiries:

 

Schroder Investment Management Limited

 

Augustine Chipungu (Press)

Kirsty Preston

 

Kerry Higgins (Company Secretary)

 

 

020 7658 6000

 

 

020 7658 6000

 

 

Kaso Legg Communications (Financial PR)

 

Charles Gorman

Henry Taylor

Effie Aye Maung Hider

 

 

 

 

IBT@kl-communications.com

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABVLLLZZLFBBZ

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.